Published in J Neurosci on April 15, 2015
The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment. Mol Neurodegener (2016) 1.38
Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. Brain (2016) 1.01
A polarizing question: do M1 and M2 microglia exist? Nat Neurosci (2016) 1.00
Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina. Sci Rep (2016) 0.88
Targeting innate immunity for neurodegenerative disorders of the central nervous system. J Neurochem (2016) 0.85
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ. Proc Natl Acad Sci U S A (2015) 0.82
Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide. Oxid Med Cell Longev (2015) 0.81
Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models. Brain Behav Immun (2016) 0.80
Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity. Am J Pathol (2016) 0.78
Gene expression profiling in stroke: relevance of blood-brain interaction. Curr Opin Pharmacol (2015) 0.77
Microglial immunophenotype in dementia with Alzheimer's pathology. J Neuroinflammation (2016) 0.76
Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier. Int J Nanomedicine (2016) 0.76
Old Maids: Aging and Its Impact on Microglia Function. Int J Mol Sci (2017) 0.75
Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe? Oxid Med Cell Longev (2017) 0.75
The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits. Hum Mol Genet (2016) 0.75
The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease. Neuroimage (2016) 0.75
Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist. Neuropharmacology (2017) 0.75
Association of Serum Manganese Levels with Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Nutrients (2017) 0.75
Expanding the phenotype in argininosuccinic aciduria: need for new therapies. J Inherit Metab Dis (2017) 0.75
Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury. Cell Death Dis (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 10.61
Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol (2005) 9.27
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci (2007) 6.23
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med (2007) 5.87
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol (1997) 4.29
Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog (2009) 4.12
The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci (2012) 4.11
The myeloid cells of the central nervous system parenchyma. Nature (2010) 3.80
Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci (2005) 3.77
Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (1996) 3.58
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett (1987) 3.13
CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 3.13
The microglial sensome revealed by direct RNA sequencing. Nat Neurosci (2013) 2.73
Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol (2008) 2.59
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem (2004) 2.45
Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging (2005) 2.44
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol (1988) 2.42
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol (2009) 2.35
Rods and cones in the mouse retina. II. Autoradiographic analysis of cell generation using tritiated thymidine. J Comp Neurol (1979) 2.35
Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat Neurosci (2013) 2.35
Arginine metabolism: boundaries of our knowledge. J Nutr (2007) 2.33
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci (2011) 2.31
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation (2006) 2.23
Arginine metabolism and nutrition in growth, health and disease. Amino Acids (2008) 2.13
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol (2011) 2.13
Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat Protoc (2006) 2.12
Brain microglia constitutively express beta-2 integrins. J Neuroimmunol (1990) 2.09
A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet (2005) 2.04
Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol (2011) 1.97
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science (2008) 1.97
Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol (2010) 1.91
Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88
Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia (2002) 1.79
Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci U S A (2001) 1.78
Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol (2008) 1.75
Macrophages and immunologic inflammation of the kidney. Semin Nephrol (2010) 1.71
Molecular biology of nitric oxide synthases. Cancer Metastasis Rev (1998) 1.66
Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease. Neurodegener Dis (2010) 1.66
Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J Neurosci (2008) 1.64
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation. Sci Transl Med (2013) 1.62
Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol (2009) 1.57
Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci (1999) 1.54
Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr (2006) 1.50
Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide (1999) 1.38
Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation (2008) 1.38
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35
Structure and function of cationic amino acid transporters (CATs). J Membr Biol (2007) 1.35
Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol (1997) 1.33
Metabolic stress in autophagy and cell death pathways. Cold Spring Harb Perspect Biol (2012) 1.30
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer. J Immunol (2011) 1.28
CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J Neurosci (2011) 1.27
Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad Sci U S A (2007) 1.26
Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation. J Biol Chem (2008) 1.24
Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis. J Clin Oncol (1984) 1.20
Adaptation of plasma membrane amino acid transport mechanisms to physiological demands. Pflugers Arch (2002) 1.15
Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells. Cancer Immunol Immunother (2008) 1.15
Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 1.14
CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci (2000) 1.14
Dispensable and indispensable amino acids for humans. J Nutr (2000) 1.11
Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. J Neurosci Res (2005) 1.08
Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization. J Biol Chem (2014) 1.07
The value of incomplete mouse models of Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 1.06
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr Drug Targets (2003) 1.06
Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol Cell Neurosci (2007) 1.04
The novel activated microglia/macrophage WAP domain protein, AMWAP, acts as a counter-regulator of proinflammatory response. J Immunol (2010) 1.04
Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res (1990) 1.02
Adaptive regulation of the cationic amino acid transporter-1 (Cat-1) in Fao cells. J Biol Chem (1997) 1.02
Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice. Am J Physiol (1998) 1.01
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline. J Alzheimers Dis (2010) 1.01
Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses. ASN Neuro (2011) 1.01
Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness. Lancet (1987) 1.00
Expression of arginase isozymes in mouse brain. J Neurosci Res (2001) 0.99
Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development. J Cell Biol (2013) 0.99
The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J Alzheimers Dis (2008) 0.99
Species differences in the generation of reactive oxygen species by microglia. Mol Chem Neuropathol (1997) 0.97
Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut (1999) 0.97
miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes. Proc Natl Acad Sci U S A (2012) 0.97
Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem Biophys Res Commun (1997) 0.96
Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells. Biochem Pharmacol (1998) 0.96
Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence. J Neuroinflammation (2011) 0.95
Metabolic profiling of Alzheimer's disease brains. Sci Rep (2013) 0.94
Systemic immune system alterations in early stages of Alzheimer's disease. J Neuroimmunol (2013) 0.94
Programmed death 1 deficiency induces the polarization of macrophages/microglia to the M1 phenotype after spinal cord injury in mice. Neurotherapeutics (2014) 0.92
Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells. Brain Behav Immun (2013) 0.91
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. PLoS One (2010) 0.90
Arginases and arginine deficiency syndromes. Curr Opin Clin Nutr Metab Care (2012) 0.90
Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines. Dig Dis Sci (1993) 0.89
Osteopontin shapes immunosuppression in the metastatic niche. Cancer Res (2014) 0.88
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice. Transl Psychiatry (2013) 0.87
Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription. J Immunol (2013) 0.86
Altered arginine metabolism in Alzheimer's disease brains. Neurobiol Aging (2014) 0.85
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains? Future Neurol (2013) 0.85
Quantitative PCR for detection of the OT-1 transgene. BMC Immunol (2005) 0.84
Alzheimer's disease: amino acid levels and brain metabolic status. Neurol Sci (2013) 0.84